HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Updates BMRN, CACC, GOCO Investors on Securities Class Actions and Upcoming Deadlines, Encourages Investors with Losses to Contact the Firm
November 02, 2020 14:17 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Hagens Berman updates investors in the following publicly-traded companies and urges investors who have suffered significant losses to contact the...
BMRN INVESTOR FRAUD: Hagens Berman, National Trial Attorneys, Encourages BioMarin Pharmaceutical (BMRN) Investors to Contact Its Attorneys, Securities Fraud Class Action Filed
October 13, 2020 19:16 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Hagens Berman urges BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) investors to contact the firm now. A securities fraud class action has been filed...
BMRN INVESTOR FRAUD: Hagens Berman, National Trial Attorneys, Encourages BioMarin Pharmaceutical (BMRN) Investors to Contact Its Attorneys, Securities Fraud Class Action Filed
September 29, 2020 16:40 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Sept. 29, 2020 (GLOBE NEWSWIRE) -- Hagens Berman urges BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) investors to contact the firm now. A securities fraud class action has been filed...